Impact of stereotactic body radiotherapy (SBRT) in oligoprogressive metastatic disease.
Sherif RamadanKimmen QuanKara SchnarrRosalyn A JuergensSebastien J HotteSom D MukherjeeAnil KapoorBrandon M MeyersAnand SwaminathPublished in: Acta oncologica (Stockholm, Sweden) (2022)
SBRT effectively controls locally progressing lesions but distant progression still occurs frequently. A sizeable number of patients can be salvaged by further SBRT or have minimally progressing diseases that may not warrant an immediate initiation/switch in systemic therapy. Further prospective studies are needed to validate this benefit.
Keyphrases
- radiation therapy
- end stage renal disease
- ejection fraction
- small cell lung cancer
- newly diagnosed
- chronic kidney disease
- squamous cell carcinoma
- early stage
- peritoneal dialysis
- locally advanced
- radiation induced
- prognostic factors
- lymph node
- mesenchymal stem cells
- patient reported outcomes
- cell therapy
- smoking cessation